{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:16Z","timestamp":1740106936124,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00277-023-05275-6","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T04:01:47Z","timestamp":1685419307000},"page":"1669-1676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Timing matters: An analysis of the relationship between red cell transfusion timing and hospitalization outcomes in sickle cell crisis patients using the National Inpatient Sample database"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1203-2766","authenticated-orcid":false,"given":"Zubair Hassan","family":"Bodla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0955-4640","authenticated-orcid":false,"given":"Mariam","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Niaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8272-0172","authenticated-orcid":false,"given":"Umer","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullahi Hussein","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue-Wei","family":"Luu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"5275_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC (2017) Sickle Cell Disease. N Engl J Med 376:1561\u20131573. https:\/\/doi.org\/10.1056\/NEJMra1510865","journal-title":"N Engl J Med"},{"key":"5275_CR2","unstructured":"Centers for Disease Control and Prevention (2022) Data & statistics on sickle cell disease. https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html. Accessed 13 Jan 2023"},{"key":"5275_CR3","unstructured":"Fingar KR, Owens PL, Reid LD, Mistry KB, Barrett ML (2019) Characteristics of inpatient hospital stays involving sickle cell disease, 2000\u20132016. HCUP\nStatistical Brief #251. Agency for Healthcare Research and Quality, Rockville, MD. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb251-Sickle-Cell-Disease-Stays-2016.pdf. Accessed 13 Jan 2023"},{"key":"5275_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","volume":"325","author":"OS Platt","year":"1991","unstructured":"Platt OS, Thorington BD, Brambilla DJ et al (1991) Pain in Sickle Cell Disease: Rates and Risk Factors. N Engl J Med 325:11\u201316. https:\/\/doi.org\/10.1056\/NEJM199107043250103","journal-title":"N Engl J Med"},{"key":"5275_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1182\/bloodadvances.2021006281","volume":"7","author":"KM Johnson","year":"2023","unstructured":"Johnson KM, Jiao B, Ramsey SD et al (2023) Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. Blood Adv 7:365\u2013374. https:\/\/doi.org\/10.1182\/bloodadvances.2021006281","journal-title":"Blood Adv"},{"key":"5275_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN et al (2014) Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. JAMA 312:1033. https:\/\/doi.org\/10.1001\/jama.2014.10517","journal-title":"JAMA"},{"key":"5275_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ejh.13430","volume":"105","author":"DS Darbari","year":"2020","unstructured":"Darbari DS, Sheehan VA, Ballas SK (2020) The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management. Eur J Haematol 105:237\u2013246. https:\/\/doi.org\/10.1111\/ejh.13430","journal-title":"Eur J Haematol"},{"key":"5275_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/asheducation-2016.1.625","volume":"2016","author":"J Howard","year":"2016","unstructured":"Howard J (2016) Sickle cell disease: when and how to transfuse. Hematology 2016:625\u2013631. https:\/\/doi.org\/10.1182\/asheducation-2016.1.625","journal-title":"Hematology"},{"key":"5275_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","volume":"4","author":"ST Chou","year":"2020","unstructured":"Chou ST, Alsawas M, Fasano RM et al (2020) American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 4:327\u2013355. https:\/\/doi.org\/10.1182\/bloodadvances.2019001143","journal-title":"Blood Adv"},{"key":"5275_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1537-2995.1987.27387235626.x","volume":"27","author":"E Schmalzer","year":"1987","unstructured":"Schmalzer E, Lee J, Brown A et al (1987) Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels Implications Transfusion. Transfusion 27:228\u2013233. https:\/\/doi.org\/10.1046\/j.1537-2995.1987.27387235626.x","journal-title":"Transfusion"},{"key":"5275_CR11","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1111\/trf.13155","volume":"55","author":"M Nouraie","year":"2015","unstructured":"Nouraie M, Gordeuk VR (2015) Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis: blood transfusion in scd admissions. Transfusion 55:2331\u20132338. https:\/\/doi.org\/10.1111\/trf.13155","journal-title":"Transfusion"},{"key":"5275_CR12","unstructured":"Agency for Healthcare Research and Quality (2020) ICD-10-CM\/PCS Resources. Healthcare Cost and Utilization Project (HCUP). http:\/\/www.hcup-us.ahrq.gov\/datainnovations\/icd10_resources.jsp. Accessed 13 Jan 2023"},{"key":"5275_CR13","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1038\/s41598-020-58934-3","volume":"10","author":"V Kumar","year":"2020","unstructured":"Kumar V, Chaudhary N, Achebe MM (2020) Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis. Sci Rep 10:2082. https:\/\/doi.org\/10.1038\/s41598-020-58934-3","journal-title":"Sci Rep"},{"key":"5275_CR14","doi-asserted-by":"publisher","unstructured":"Farooq U, Tarar Z, Malik A et al (2022) How does cirrhosis impact mortality, morbidity, and resource utilization in non-variceal upper gastrointestinal bleeding? A nationwide analysis. Gastroenterol Rev\/Prz Gastroenterol 17. https:\/\/doi.org\/10.5114\/pg.2022.115232","DOI":"10.5114\/pg.2022.115232"},{"key":"5275_CR15","unstructured":"United States Department of Labor: U.S. Bureau of Labor Statistics CPI Inflation Calculator. https:\/\/data.bls.gov\/cgi-bin\/cpicalc.pl. Accessed 5 Apr 2023"},{"key":"5275_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bjh.14383","volume":"176","author":"BA Davis","year":"2017","unstructured":"Davis BA, Allard S, Qureshi A et al (2017) Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion. Br J Haematol 176:192\u2013209. https:\/\/doi.org\/10.1111\/bjh.14383","journal-title":"Br J Haematol"},{"key":"5275_CR17","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","volume":"51","author":"M LaSalle-Williams","year":"2011","unstructured":"LaSalle-Williams M, Nuss R, Le T et al (2011) Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME): minor antigen matching for sickle cell disease. Transfusion 51:1732\u20131739. https:\/\/doi.org\/10.1111\/j.1537-2995.2010.03045.x","journal-title":"Transfusion"},{"key":"5275_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3889\/oamjms.2017.054","volume":"5","author":"T Makarovska-Bojadzjieva","year":"2017","unstructured":"Makarovska-Bojadzjieva T, Velkova E, Blagoevska M (2017) The Impact of Extended Typing On Red Blood Cell Alloimmunization in Transfused Patients. Open Access Maced J Med Sci 5:107\u2013111. https:\/\/doi.org\/10.3889\/oamjms.2017.054","journal-title":"Open Access Maced J Med Sci"},{"key":"5275_CR19","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet 376:2018\u20132031. https:\/\/doi.org\/10.1016\/S0140-6736(10)61029-X","journal-title":"Lancet"},{"key":"5275_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1108\/17506121011095182","volume":"4","author":"M Hassan","year":"2010","unstructured":"Hassan M, Tuckman HP, Patrick RH et al (2010) Hospital length of stay and probability of acquiring infection. Int J Pharm Healthcare Marketing 4:324\u2013338. https:\/\/doi.org\/10.1108\/17506121011095182","journal-title":"Int J Pharm Healthcare Marketing"},{"key":"5275_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1097\/MLR.0b013e31822efb09","volume":"49","author":"K Hauck","year":"2011","unstructured":"Hauck K, Zhao X (2011) How dangerous is a day in hospital? A model of adverse events and length of stay for medical inpatients. Med Care 49:1068\u20131075. https:\/\/doi.org\/10.1097\/MLR.0b013e31822efb09","journal-title":"Med Care"},{"key":"5275_CR22","unstructured":"National Heart Lung and Blood Institute (2014) Evidence-based management of sickle cell disease: expert panel report, 2014. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, [Bethesda, Maryland]. https:\/\/www.nhlbi.nih.gov\/health-topics\/evidence-based-management-sickle-cell-disease"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05275-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05275-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05275-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T06:09:50Z","timestamp":1686550190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05275-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["5275"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05275-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was exempted from the Institutional Review Board (IRB) because it was based on de-identified publicly available data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This is a retrospective study thus consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"It is a retrospective study thus consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}